Lyme Disease Research


Two vaccines look very promising for the prevention of Lyme disease. Both have been studied with three doses given initially, during the first month, and at 12 months after the first dose.

Both vaccines appear to work, decreasing Lyme disease by about 75 percent to 90 percent. Neither is yet approved by the Food and Drug Administration. It is likely that such vaccines will greatly decrease the risk of acquiring Lyme disease.

Several issues regarding the vaccines remain to be clarified. Neither have been studied in children, so the efficacy in that group remains to be determined.

Further, the duration of protection is not yet known, and therefore, the need for booster doses still needs to be evaluated.

Both comments and pings are currently closed.

Comments are closed.

VPS Hosting